(Q45362381)

English

Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy

scientific article published on 18 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Kun Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Deyu Jiang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Liangyan Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Zhidong Yao

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Zhongwei Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sanke Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Xiliang Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

18 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

3034-3041

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Chromatin control of herpes simplex virus lytic and latent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Herpes Simplex: Insights on Pathogenesis and Possible Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Novel approaches in fighting herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Antibody response to herpes simplex virus glycoproteins gB and gD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. An analysis of linker insertion mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Improved method for predicting linear B-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Ex vivo analysis of T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Immune mechanisms by which the spread of viral infections is stopped

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Differential T cell response induced by certain recombinant oligopeptides of herpes simplex virus glycoprotein B in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

The nucleotide sequence of herpes simplex virus type 2 (333) glycoprotein gB2 and analysis of predicted antigenic sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.10.010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45362381&oldid=2075851373"